NEW YORK – Qiagen reported after the close of the market on Tuesday that its second quarter revenues jumped 16 percent year over year due primarily to high demand for products related to SARS-CoV-2 molecular diagnostic testing.
NEW YORK – Qiagen reported after the close of the market on Tuesday that its second quarter revenues jumped 16 percent year over year due primarily to high demand for products related to SARS-CoV-2 molecular diagnostic testing.
...and receive Daily News bulletins.
Already have a GenomeWeb or 360Dx account?
Login Now.
Don't have a GenomeWeb or 360Dx account?
Register for Free.